Aptus Pharma Board Meeting on Aug 17 to Consider Preferential Issue

Aptus Pharma Ltd has announced a Board of Directors meeting scheduled for August 17, 2026, to consider and approve a preferential issue of 16,10,100 equity shares. The agenda includes taking on record the valuation report, determining the issue price based on a registered valuer's report, and approving PCS and Auditor certificates for compliance. The company will also convene its 16th Annual General Meeting on September 14, 2026. Concurrently, the trading window for designated persons and their immediate relatives will be closed from August 12, 2026, until 48 hours after the board meeting outcome is disseminated, in compliance with SEBI PIT Regulations.